Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

3 Biotech Stocks on Track for 50% Returns (or More) by 2028

Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!

What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.

Figuring out the hottest biotech stocks can be as simple as looking at the most traded stocks by volume in the last 24 hours.

3 Biotech Stocks That Could Have Investors Grinning Soon

Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential.

DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split

Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month.

ME Stock Alert: CEO Anne Wojcicki Enters $200 Million Buyout Offer for 23andMe

23andMe stock is up on Friday as investors react to an offer from the company's founder to take it private for 40 cents per share for ME.

7 Subdued Blue-Chip Stocks That Will Reward Patient Investors

These are the blue-chip stocks to buy as they represent companies with strong fundamentals and growth acceleration possibility.

Why is Immuneering (IMRX) Stock Up 24% Today?

Up nearly 25% in today's session on a fast track designation for a key pancreatic cancer drug candidate, IMRX stock is coming into focus.

Arbutus Layoffs 2024: What to Know About the Latest ABUS Job Cuts

While the Arbutus layoffs represents a major overhaul operationally, the market has responded positively to ABUS stock. Here’s why.

Why Is RedHill Biopharma (RDHL) Stock Up 75% Today?

One of today's biggest market movers in the biotech space is RedHill Biuopharma, with RDHL stock up more than 75% on big news.

FibroGen Layoffs 2024: What to Know About the Latest FGEN Job Cuts

FibroGen layoffs are in the news Wednesday after the biopharmaceutical company announced plans to cut jobs after failed clinical trials.

7 Top Stocks Under $10: July 2024 Edition

There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.

Why is Macrogenics (MGNX) Stock Down 28% Today?

Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.

Why Is FibroGen (FGEN) Stock Down 44% Today?

FibroGen stock is down on Wednesday as FGEN investors react to the company's failed clinical trials for its pancreatic cancer treatment.

The Top 3 Healthcare Stocks to Buy Now: Summer 2024

Investors should consider the long term prospects of the following three healthcare stocks as the U.S. population ages.

Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?

Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates.

7 Stocks Set for a Major Bull Run

Explore top stocks to buy, leading in social media, semiconductors, entertainment, restaurants, payments and biotechnology.

3 Biotech Stocks That Could Make Your Summer Unforgettable

If you want to do well with biotech stocks, trade the anticipation of news. Here are three stocks to consider.

JPMorgan Just Issued a Warning on Novavax (NVAX) Stock

Novavax has inked a key vaccine deal with Sanofi, but NVAX stock is down after JPMorgan warned about overvaluation concerns.

SAVA Stock: Cassava Sciences Extends Simufilam Trials as Much as 36 Months

Cassava Sciences has announced plans to extend trials for its Alzheimer’s treatment drug. This news isn't helping SAVA stock.